Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


SCCA at EvergreenHealth

Below are some of the SCCA clinical trials now being offered for patients at the SCCA at EvergreenHealth in Kirkland. If you have any questions about these or other trials, please contact the clinical trial coordinator at (425) 899-3337.

Breast Cancer (Newly Diagnosed)

Breast Cancer (Recurrent/Metastatic)

  • Triple Negative (6628)
    Combined Targeted Therapies for Triple Negative Advanced Breast Cancer - A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib
  • A Randomized, Multicenter, Double-Blind Phase 3 Study Of PD-0332991 (Oral CDK 4/6 Inhibitor) Plus Letrozole Versus Placebo Plus Letrozole For The Treatment Of Postmenopausal Women With ER (+), HER2 (-) Breast Cancer Who Have Not Received Any Prior Systemic Anti Cancer Treatment For Advanced Disease

Colon Cancer (Newly Diagnosed/Recurrent)

Gynecologic Cancer

Leukemia (Newly Diagnosed)

  • Vorinostat + Chemotherapy for CLL or SLL (PSOC-2401)
    A Phase I/II Study of Fludarabine (F), Cyclophosphamide ©), Rituximab ®), and Vorinostat (V) Followed by RV Maintenance Therapy in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small LymphoCtic Lymphoma (SLL)

Lung Cancer

Lymphoma (Newly Diagnosed)

Lymphoma (Recurrent/Metastatic)

Prostate Cancer